1-14 of 14
Mark J Bishton
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Tracking Immune Cell Subsets and Activation Profiles in Adults with Haemophagocytic Lymphohistiocytosis Treated with Anakinra

Emma Hadfield, David Onion, Mark J Bishton
Journal: Blood
Blood (2024) 144 (Supplement 1): 5370.
https://doi.org/10.1182/blood-2024-197905
Published: 2024
Journal Articles

A Prospective Analysis of Outcomes Following Successive Lines of Treatment in Mantle Cell Lymphoma in an Unselected Previously Untreated Population: The UK MCL Biobank

Sarah Mant, Georgina Naylor, Nicola Crosbie, Sree Aroori, Mark J Bishton, Kristian Bowles, Safia Dawi, Toby A. Eyre, Wendy Ingram, Abigail Martin, Christopher McNamara, Melanie Oates, Andrew Pettitt, Claire Scully, Brian Wainman, Mark Warner, Simon Rule, David John Lewis
Journal: Blood
Blood (2024) 144 (Supplement 1): 1641.
https://doi.org/10.1182/blood-2024-209701
Published: 2024
Journal Articles

Targeting Cks1b in Multiple Myeloma Using Fluoxetine

Alice Worker, Dean Smith, Martin Grundy, Joanne Lindsey-Hill, Tanatswa Makore, Mark J Bishton, Claire Seedhouse
Journal: Blood
Blood (2024) 144 (Supplement 1): 6811.
https://doi.org/10.1182/blood-2024-194791
Published: 2024
Journal Articles

A Multi-Centre Study of Outcomes of Anakinra for Trigger Factors of Adult Hemophagocytic Lymphohistiocytosis in England

Nicola J Whiteside, Catherine Loughran, Niteesh Bharadwaj, Robin Badger, Meheroon Nahar, Mark J Bishton
Journal: Blood
Blood (2024) 144 (Supplement 1): 5375.
https://doi.org/10.1182/blood-2024-205551
Published: 2024
Journal Articles

Ibrutinib-Rituximab Is Superior to Rituximab-Chemotherapy in Previously Untreated Older Mantle Cell Lymphoma Patients: Results from the International Randomised Controlled Trial, Enrich

David John Lewis, Mats Jerkeman, Lexy Sorrell, David Wright, Ingrid Glimelius, Annika Pasanen, Jacob Haaber Christensen, Karin Fahl Wader, Andrew J. Davies, Nick Morley, Christopher McNamara, Christian Bjørn Poulsen, Jon Riise, Kristina Sonnevi, Ingemar Lagerlöf, Cathy Burton, Surita Dalal, Andrew Rawstron, Ruth M de Tute, Victoria Allgar, Sree Aroori, Mark Warner, Brian Wainman, Claire Scully, Jeanette Sanders, Carsten Utoft Niemann, Helle Toldbod, Nicola Crosbie, Mark J Bishton, Toby A. Eyre, Simon Rule
Journal: Blood
Blood (2024) 144 (Supplement 1): 235.
https://doi.org/10.1182/blood-2024-199710
Published: 2024
Journal Articles

Daratumumab, Bortezomib and Dexamethasone for Previously Treated Myeloma - Comparing Real-World Outcomes in England to the Castor Phase III Clinical Trial

Sarah Lawton, Mark J Bishton, Peter Clark, Katherine Thackray, Dean Smith
Journal: Blood
Blood (2024) 144 (Supplement 1): 3778.
https://doi.org/10.1182/blood-2024-207341
Published: 2024
Journal Articles

High-Dose Methotrexate Is Not Associated with Reduction in CNS Relapse in Patients with Aggressive B-Cell Lymphoma: An International Retrospective Study of 2300 High-Risk Patients

Katharine Louise Lewis, Lasse H. Jakobsen, Diego Villa, Sabela Bobillo, Karin Ekstroem Smedby, Kerry J. Savage, Toby A. Eyre, Kate Cwynarski, Paris L Caporn, Joan Van Zyl, Magdalena Klanova, Marek Trněný, Robert Puckrin, Douglas A. Stewart, Mark J Bishton, Christopher P. Fox, Aung M Tun, Gita Thanarajasingam, Faouzi Djebbari, Erel Joffe, Sandra Eloranta, Sara Harrysson, Laurie H. Sehn, Seth M Maliske, Kittika Poonsombudlert, Xiao Guo, Greg Hapgood, Kate Manos, Eliza Hawkes, Jahanzaib Khwaja, Adrian Minson, Michael Dickinson, Andreas Kiesbye Øvlisen, Gareth P Gregory, Michael Gilbertson, Isaac T Streit, Hamish W Scott, Matthew Ku, Sanjay de Mel, Kar Ying Yong, Liu Xin, Mridula Mokoonlall, Dipti Talaulikar, Nicholas L McVilly, Anna Johnston, Matthew J Brunner, Priyanka A Pophali, Matthew J. Maurer, Tarec Christoffer El-Galaly, Chan Yoon Cheah
Journal: Blood
Blood (2021) 138 (Supplement 1): 181.
https://doi.org/10.1182/blood-2021-146737
Published: 2021
Journal Articles

The Pan Histone Deacetylase Inhibitor Panobinostat and the Iso-Selective Inhibitor Romidepsin Reduce Glycoprotein VI Expression and Inhibit Platelet Activation in Response to Collagen Related Peptide

Mark J Bishton, Miles Prince, MD, FRACP, FRCPA, Ricky W Johnstone, PhD, Simon J. Harrison, MBBS MRCP (uk) MRCPath (uk) PhD, Benjamin T. Kile, PhD
Journal: Blood
Blood (2011) 118 (21): 1154.
https://doi.org/10.1182/blood.V118.21.1154.1154
Published: 2011
Journal Articles

Deciphering the molecular and biologic processes that mediate histone deacetylase inhibitor–induced thrombocytopenia

Mark J. Bishton, Simon J. Harrison, Benjamin P. Martin, Nicole McLaughlin, Chloé James, Emma C. Josefsson, Katya J. Henley, Benjamin T. Kile, H. Miles Prince, Ricky W. Johnstone
Journal: Blood
Blood (2011) 117 (13): 3658–3668.
https://doi.org/10.1182/blood-2010-11-318055
Published: 2011
Includes: Supplemental data
Journal Articles

Overcoming Histone Deacetylase Inhibitor Induced Thrombocytopenia Using a Thrombopoietin Mimetic.

Mark J Bishton, Miles Prince, Simon Harrison, Ben P Martin, Bsc, (Hons), Chloé James, MD, PhD, Benjamin T. Kile, PhD, R. W Johnstone
Journal: Blood
Blood (2009) 114 (22): 2416.
https://doi.org/10.1182/blood.V114.22.2416.2416
Published: 2009
Journal Articles

A Prospective Study of the Prognostic Impact of 18 [F]-FDG-PET and Molecular Response in Patients with Relapsed Indolent Non-Hodgkin Lymphoma (NHL) Following Iodine-131-Rituximab Radio-Immunotherapy (RIT).

Mark J. Bishton, MB, ChB, Rod Hicks, David Alan Westerman, Miles Prince, Max Wolf, John Francis Seymour
Journal: Blood
Blood (2007) 110 (11): 3421.
https://doi.org/10.1182/blood.V110.11.3421.3421
Published: 2007
Journal Articles

Repeat Treatment with Iodine-131-Rituximab Is Safe and Effective in Patients with Relapsed Indolent B-Cell Non-Hodgkin Lymphoma (NHL) Who Had Previously Responded to This Therapy.

Mark J. Bishton, MB, ChB, Michael F. Leahy, Rod J. Hicks, J. Harvey Turner, Ad McQuillan, John Francis Seymour
Journal: Blood
Blood (2007) 110 (11): 3413.
https://doi.org/10.1182/blood.V110.11.3413.3413
Published: 2007
Journal Articles

Treatment of Enteropathy Associated T Cell Lymphoma with Combination Chemotherapy Followed by Autologous Stem Cell Transplantation.

Mark J. Bishton, Andrew P. Haynes, Jenny L. Byrne, Nigel H. Russell
Journal: Blood
Blood (2006) 108 (11): 5424.
https://doi.org/10.1182/blood.V108.11.5424.5424
Published: 2006
Journal Articles

Ifosphamide, Etoposide and Epirubicin (IVE) Is an Effective Combined Salvage and Peripheral Blood Stem Cell Mobilisation Regimen for Transplant-Eligible Patients with Lymphoma.

Mark J. Bishton, Richard Lush, Nigel H. Russell, Bronwen E. Shaw, Andrew P. Haynes
Journal: Blood
Blood (2006) 108 (11): 2432.
https://doi.org/10.1182/blood.V108.11.2432.2432
Published: 2006